Thrombomodulin-Protein C-EPCR System
Top Cited Papers
- 1 August 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (8) , 1374-1383
- https://doi.org/10.1161/01.atv.0000134298.25489.92
Abstract
Late in the 18th century, William Hewson recognized that the formation of a clot is characteristic of many febrile, inflammatory diseases (Owen C. A History of Blood Coagulation. Rochester, Minnesota: Mayo Foundation; 2001). Since that time, there has been steady progress in our understanding of coagulation and inflammation, but it is only in the past few decades that the molecular mechanisms linking these 2 biologic systems have started to be delineated. Most of these can be traced to the vasculature, where the systems most intimately interact. Thrombomodulin (TM), a cell surface-expressed glycoprotein, predominantly synthesized by vascular endothelial cells, is a critical cofactor for thrombin-mediated activation of protein C (PC), an event further amplified by the endothelial cell protein C receptor (EPCR). Activated PC (APC), in turn, is best known for its natural anticoagulant properties. Recent evidence has revealed that TM, APC, and EPCR have activities that impact not only on coagulation but also ...Keywords
This publication has 109 references indexed in Scilit:
- Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharideBlood, 2004
- Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulationBlood Coagulation & Fibrinolysis, 2003
- Expression and function of the endothelial protein C receptor in human neutrophilsBlood, 2003
- Soluble thrombomodulin and coronary heart diseaseCurrent Opinion in Lipidology, 2003
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003
- Effects of human soluble thrombomodulin on experimental glomerulonephritisKidney International, 2002
- Molecular Model for the C-type Lectin Domain of Human ThrombomodulinJournal of Molecular Modeling, 1998
- Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor‐induced disseminated intravascular coagulation in ratsAmerican Journal of Hematology, 1994
- Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.Journal of Clinical Investigation, 1991
- Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the NewbornNew England Journal of Medicine, 1984